Search
for
Sort by
Research 31–60 of 309
- Resolution of the plantar hyperkeratosis of pachyonychia congenita during chemotherapy for Ewing sarcoma
- Toxic Side Effects of Targeted Therapies and Immunotherapies Affecting the Skin, Oral Mucosa, Hair, and Nails
- Hair disorders in patients with cancer
- Efficacy and tolerability of two scalp cooling systems for the prevention of alopecia associated with docetaxel treatment
- Steroidal 5α-reductase and 17α-hydroxylase/17,20-lyase (CYP17) inhibitors useful in the treatment of prostatic diseases
- Malignancy and Cancer Treatment-Related Hair and Nail Changes
- Pathogenesis and treatment options for chemotherapy‐induced alopecia: a systematic review
- Alopecia in Association with Malignancy: A Review
- Safety of 5α-reductase inhibitors and spironolactone in breast cancer patients receiving endocrine therapies
- First-line therapy with gemcitabine and paclitaxel in locally, recurrent or metastatic breast cancer: A phase II study
- Recent discoveries and developments of androgen receptor based therapy for prostate cancer
- Dermatologic Adverse Events from Cancer Treatments
- Sacituzumab tirumotecan (sac-TMT/MK-2870/SKB264): a novel antibody–drug conjugate in breast cancer
- Poster Abstracts
- Chemotherapy-induced iatrogenic injury of skin: New drugs and new concepts
- Real-world pharmacovigilance insights into drug-induced risk of alopecia
- Subject Index
- Chemotherapy-Induced Hair Loss: The Use of Biomarkers for Predicting Alopecic Severity and Treatment Efficacy
- Permanent chemotherapy-induced alopecia: Case report and review of the literature
- Low-level laser treatment accelerated hair regrowth in a rat model of chemotherapy-induced alopecia (CIA)
- Selenium as an element in the treatment of ovarian cancer in women receiving chemotherapy
- Female Pattern Hair Loss
- Oral minoxidil for late alopecia in cancer survivors
- Efficacy of bimatoprost in treating chemotherapy-induced milphosis: A comprehensive review of randomized controlled trials
- Efficacy and safety of trastuzumab deruxtecan in the treatment of HER2-low/positive advanced breast cancer: a single-arm meta-analysis
- Clinicopathologic Characteristics and Response to Treatment of Persistent Chemotherapy-Induced Alopecia in Breast Cancer Survivors
- Perspective Chapter: Appraisal of Paclitaxel (Taxol) Pros and Cons in the Management of Cancer – Prospects in Drug Repurposing
- Impact of Reporter Type on Signal Detection of Cancer Therapy-Induced Alopecia: A Hypothesis-Generating Study Using the FDA Adverse Event Reporting System
- Feasibility and tolerability of eribulin-based chemotherapy versus other chemotherapy regimens for patients with metastatic triple-negative breast cancer: a single-centre retrospective study
- Effectiveness and safety of standard chemotherapy in older patients with ovarian cancer: a retrospective analysis by age group and treatment regimen